Review ArticleClinical Review

Diagnosis and Management of Hypermobility Spectrum Disorders in Primary Care

Karina Atwell, William Michael, Jared Dubey, Sarah James, Andrea Martonffy, Scott Anderson, Nathan Rudin and Sarina Schrager
The Journal of the American Board of Family Medicine July 2021, 34 (4) 838-848; DOI: https://doi.org/10.3122/jabfm.2021.04.200374

References

  1. 1.↵
    1. Hakim AJ,
    2. Grahame R
    . A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract 2003;57:163–6.
    OpenUrlPubMed
  2. 2.↵
    1. Fikree A,
    2. Aziz Q,
    3. Grahame R
    . Joint hypermobility syndrome. Rheum Dis Clin North Am 2013;39:419–30.
    OpenUrlCrossRefPubMed
  3. 3.↵
    2017 International Diagnostic Criteria for hEDS. 2021. Available from: https://ehlers-danlos.com/wp-content/uploads/hEDS-Dx-Criteria-checklist-1.pdf.
  4. 4.↵
    1. Kirk JA,
    2. Ansell BM,
    3. Bywaters EG
    . The hypermobility syndrome: musculoskeletal complaints associated with generalized joint hypermobility. Ann Rheum Dis 1967;26:419–25.
    OpenUrlFREE Full Text
  5. 5.↵
    1. Malfait F,
    2. Francomano C,
    3. Byers P
    . The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017;175:8–26.
    OpenUrlCrossRefPubMed
  6. 6.↵
    What is HSD. 2021. Available from: https://www.ehlers-danlos.com/what-is-hsd/.
  7. 7.↵
    1. Castori M,
    2. Tinkle B,
    3. Levy H,
    4. Grahame R,
    5. Malfait F,
    6. Hakim A
    . A framework for the classification of joint hypermobility and related conditions. Am J Med Genet Part C Semin Med Genet 2017;175;148–57.
    OpenUrl
  8. 8.↵
    1. Russek LN,
    2. Errico DM
    . Prevalence, injury rate and symptom frequency in generalized joint laxity and joint hypermobility syndrome in a “healthy” college population. Clin Rheumatol 2016;35:1029–39.
    OpenUrlPubMed
  9. 9.↵
    1. Reuter PR,
    2. Fichthorn KR
    . Prevalence of generalized joint hypermobility, musculoskeletal injuries, and chronic musculoskeletal pain among American university students. Peer J 2019;7:e7625.
    OpenUrl
  10. 10.↵
    1. Kumar B,
    2. Lenert P
    . Joint hypermobility syndrome: recognizing a commonly overlooked cause of chronic pain. Am J Med 2017;130:640–7.
    OpenUrlCrossRef
  11. 11.↵
    1. Castori M,
    2. Sperduti I,
    3. Celletti C,
    4. Camerota F,
    5. Grammatico P
    . Symptom and joint mobility progression in the joint hypermobility syndrome (Ehlers–Danlos syndrome, hypermobility type). Clin Exp Rheumatol 2011;29:998–1005.
    OpenUrlPubMed
  12. 12.↵
    1. Syx D,
    2. Wandele I,
    3. Rombaut L,
    4. Malfait F
    . Hypermobility, the Ehlers-Danlos syndromes and chronic pain. Clin Exp Rheumatol 2017;35:S116–S122.
    OpenUrl
  13. 13.↵
    1. Castori M,
    2. Morlino S,
    3. Celletti C,
    4. et al
    . Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet A 2013;161A:2989–3004.
    OpenUrlCrossRef
  14. 14.↵
    1. Bates AV,
    2. Alexander CM
    . Kinematics and kinetics of people who are hypermobile: a systematic review. Gait Posture 2015;41:361–9.
    OpenUrl
  15. 15.↵
    1. Pacey V,
    2. Nicholson LL,
    3. Adams RD,
    4. et al
    . Generalized joint hypermobility and risk of lower limb joint injury during sport: a systematic review with meta-analysis. Am J Sports Med 2010;38:1487–97.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Rombaut L,
    2. Malfait F,
    3. De Wandele I,
    4. et al
    . Muscle mass, muscle strength, functional performance, and physical impairment in women with the hypermobility type of Ehlers-Danlos syndrome. Arthritis Care Res (Hoboken) 2012;64:1584–92.
    OpenUrl
  17. 17.↵
    1. Rombaut L,
    2. Scheper M,
    3. De Wandele I,
    4. et al
    . Chronic pain in patients with the hypermobility type of Ehlers-Danlos syndrome: evidence for generalized hyperalgesia. Clin Rheumatol 2015;34:1121–9.
    OpenUrlPubMed
  18. 18.↵
    1. Scheper M,
    2. de Vries J,
    3. Verbunt J,
    4. et al
    . Chronic pain in hypermobility syndrome and Ehlers-Danlos syndrome (hypermobility type): it is a challenge. J Pain Res 2015;8:591–601.
    OpenUrl
  19. 19.↵
    1. Hakim AJ,
    2. Sahota A
    . Joint hypermobility and skin elasticity: the hereditary disorders of connective tissue. Clin Dermatol 2006;24:521–33.
    OpenUrlPubMed
  20. 20.↵
    1. Tinkle BT,
    2. Levy HP
    . Symptomatic joint hypermobility: the hypermobile type of Ehlers-Danlos syndrome and the hypermobility spectrum disorders. Med Clin North Am 2019;103:1021–33.
    OpenUrl
  21. 21.↵
    1. Beckers AB,
    2. Keszthelyi D,
    3. Fikree A,
    4. et al
    . Gastrointestinal disorders in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type: a review for the gastroenterologist. Neurogastroenterol Motil 2017;29:e13013.
    OpenUrlPubMed
  22. 22.↵
    1. Sundelin HE,
    2. Stephansson O,
    3. Johansson K,
    4. Ludvigsson JF
    . Pregnancy outcome in joint hypermobility syndrome and Ehlers-Danlos syndrome. Acta Obstet Gynecol Scand 2017;96:114–9.
    OpenUrl
  23. 23.↵
    1. Karthikeyan A,
    2. Venkat-Raman N
    . Hypermobile Ehlers-Danlos syndrome and pregnancy. Obstet Med 2018;11:104–9.
    OpenUrl
  24. 24.↵
    1. Bulbena A,
    2. Duro JC,
    3. Mateo A,
    4. Porta M,
    5. Vallejo J
    . Joint hypermobility syndrome and anxiety disorders. Lancet 1988;2:694.
    OpenUrlPubMed
  25. 25.↵
    1. Bulbena A,
    2. Duro JC,
    3. Porta M,
    4. et al
    . Anxiety disorders in the joint hypermobility syndrome. Psychiatry Res 1993;46:59–68.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Martín-Santos R,
    2. Bulbena A,
    3. Porta M,
    4. Gago J,
    5. Molina L,
    6. Duró JC
    . Association between joint hypermobility syndrome and panic disorder. AJP 1998;155:1578–83.
    OpenUrl
  27. 27.↵
    1. Pailhez G,
    2. Castano J,
    3. Rosado S,
    4. et al
    . 2015. Joint hypermobility, anxiety, and psychosomatics—the new neuroconnective phenotype. Available from: https://www.intechopen.com/books/a-fresh-look-at-anxiety-disorders/joint-hypermobility-anxiety-and-psychosomatics-the-new-neuroconnective-phenotype.
  28. 28.↵
    1. Eccles JA,
    2. Beacher FDC,
    3. Gray MA,
    4. Jones CL,
    5. et al
    . Brain structure and joint hypermobility: relevance to the expression of psychiatric symptoms. Br J Psychiatry 2012;200:508–9.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Gazit Y,
    2. Nahir AM,
    3. Grahame R,
    4. Jacob G
    . Dysautonomia in the joint hypermobility syndrome. Am J Med 2003;115:33–40.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Hakim A,
    2. O'Callaghan C,
    3. De Wandele I,
    4. Stiles L,
    5. Pocinki A,
    6. Rowe P
    . Cardiovascular autonomic dysfunction in Ehlers-Danlos syndrome—hypermobile type. Am J Med Genet C Semin Med Genet 2017;175:168–74.
    OpenUrlCrossRef
  31. 31.↵
    1. Chora P,
    2. Tinkle B,
    3. Hamonet C,
    4. et al
    . Pain management in the Ehlers-Danlos syndromes. Am J Med Genet Part C Semin Med Genet 2017;9999C:1–8.
    OpenUrl
  32. 32.↵
    1. Bravo J,
    2. Sanhueza FG,
    3. Hakim AJ
    . Cardiovascular autonomic dysfunction and chronic fatigue in fibromyalgia and joint hypermobility syndrome. In: Hypermobility, fibromyalgia and chronic pain. London: Churchill Livingstone; 2010. p. 69–82.
  33. 33.↵
    1. Simmonds JV,
    2. Keer RJ
    . Hypermobility and the hypermobility syndrome, part 2: assessment and management of hypermobility syndrome: illustrated via case studies. Man Ther 2008;13:e1–e11.
    OpenUrlPubMed
  34. 34.↵
    1. Simpson M
    . Benign joint hypermobility syndrome: evaluation, diagnosis, and management. J Am Osteopath Assoc 2006;106:531–63.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Hauser RA,
    2. Phillips HJ
    . Treatment of joint hypermobility syndrome, including Ehlers-Danlos syndrome, with Hackett-Hemwall prolotherapy. Journal of Prolo 2011;3:612–29.
    OpenUrl
  36. 36.↵
    1. Hamonet C,
    2. Laouar R,
    3. Vienne M,
    4. Brissot R,
    5. Bernard J-C,
    6. Comberg A
    . V^etements compressifs et syndrome d'Ehlers-Danlos. Etude multicentrique et prospective sur 49 personnes du handicap avec le Handitest. Journal de Readaptation Medicale 2010;30:184–91.
    OpenUrl
  37. 37.↵
    1. Hamonet C,
    2. Brock I
    . Joint mobility and Ehlers-Danlos syndrome (EDS): new data based on 232 cases. J Arthritis 2015;4:148.
    OpenUrl
  38. 38.↵
    1. Ferrell WR,
    2. Tennant N,
    3. Sturrock RD,
    4. et al
    . Amelioration of symptoms by enhancement of proprioception in patients with joint hypermobility syndrome. Arthritis Rheum 2004;50:3323–8.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Chopra P,
    2. Tinkle B,
    3. Hamonet C,
    4. et al
    . Pain management in the Ehlers–Danlos syndromes. Am J Med Genet C Semin Med Genet 2017;175:212–9.
    OpenUrlCrossRef
  40. 40.
    1. Ferrell WR,
    2. Tennant N,
    3. Sturrock RD,
    4. et al
    . Amelioration of symptoms by enhancement of proprioception in patients with joint hypermobility syndromes. Arthritis Rheumatism 2004;50:3323–8.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords